SOUTH SAN FRANCISCO, Calif. (AP) _ Cytokinetics Inc. (CYTK) on Thursday reported a loss of $32.1 million in its second quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 56 cents.
The biopharmaceutical company posted revenue of $7.1 million in the period.
Cytokinetics shares have more than doubled since the beginning of the year. In the final minutes of trading on Thursday, shares hit $13.63, an increase of 91% in the last 12 months.